Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 168

1.

How does drug treatment for diabetes compare between Medicare Advantage prescription drug plans (MAPDs) and stand-alone prescription drug plans (PDPs)?

Erten MZ, Stuart B, Davidoff AJ, Shoemaker JS, Bryant-Comstock L, Shenolikar R.

Health Serv Res. 2013 Jun;48(3):1057-75. doi: 10.1111/1475-6773.12016. Epub 2012 Dec 3.

2.

Comparison of statin adherence among beneficiaries in MA-PD plans versus PDPs.

Jung K, McBean AM, Kim JA.

J Manag Care Pharm. 2012 Mar;18(2):106-15.

3.

Impact of Part D low-income subsidies on medication patterns for Medicare beneficiaries with diabetes.

Stuart B, Yin X, Davidoff A, Simoni-Wastila L, Zuckerman I, Shoemaker JS, Doshi J.

Med Care. 2012 Nov;50(11):913-9. doi: 10.1097/MLR.0b013e31826c85f9.

PMID:
23047779
4.

Medication use and adherence among elderly Medicare beneficiaries with diabetes enrolled in Part D and retiree health plans.

Stuart B, Simoni-Wastila L, Yin X, Davidoff A, Zuckerman IH, Doshi J.

Med Care. 2011 May;49(5):511-5. doi: 10.1097/MLR.0b013e31820bf885. Erratum in: Med Care. 2011 Oct; 49(10):970.

PMID:
21422956
5.

Do Restrictions on Antipsychotic Use Differ Between Medicare Part D Stand-Alone Versus Medicare Advantage Plans?

Chou J, Brandt NJ, Loh FE, Stuart B.

Consult Pharm. 2017 Feb 1;32(2):109-118. doi: 10.4140/TCP.n.2017.109.

PMID:
28569663
6.

PDP or MA-PD? Medicare part D enrollment decisions in CMS Region 25.

Cline RR, Worley MM, Schondelmeyer SW, Schommer JC, Larson TA, Uden DL, Hadsall RS.

Res Social Adm Pharm. 2010 Jun;6(2):130-42. doi: 10.1016/j.sapharm.2010.04.002.

PMID:
20511112
7.

How Medicare Part D benefit phases affect adherence with evidence-based medications following acute myocardial infarction.

Stuart B, Davidoff A, Erten M, Gottlieb SS, Dai M, Shaffer T, Zuckerman IH, Simoni-Wastila L, Bryant-Comstock L, Shenolikar R.

Health Serv Res. 2013 Dec;48(6 Pt 1):1960-77. doi: 10.1111/1475-6773.12073. Epub 2013 Jun 6.

8.

Predictors of medication nonadherence among patients with diabetes in Medicare Part D programs: a retrospective cohort study.

Yang Y, Thumula V, Pace PF, Banahan BF 3rd, Wilkin NE, Lobb WB.

Clin Ther. 2009 Oct;31(10):2178-88; discussion 2150-1. doi: 10.1016/j.clinthera.2009.10.002.

PMID:
19922889
9.

Evaluation of an integrated adherence program aimed to increase Medicare Part D star rating measures.

Leslie RS, Tirado B, Patel BV, Rein PJ.

J Manag Care Spec Pharm. 2014 Dec;20(12):1193-203.

10.

Association between dispensing channel and medication adherence among medicare beneficiaries taking medications to treat diabetes, high blood pressure, or high blood cholesterol.

Iyengar RN, Balagere DS, Henderson RR, LeFrancois AL, Rabbitt RM, Frazee SG.

J Manag Care Spec Pharm. 2014 Aug;20(8):851-61.

11.

A Multichannel Medication Adherence Intervention Influences Patient and Prescriber Behavior.

Leslie RS, Gilmer T, Natarajan L, Hovell M.

J Manag Care Spec Pharm. 2016 May;22(5):526-38. doi: 10.18553/jmcp.2016.22.5.526.

12.

A Pharmacist Telephone Intervention to Identify Adherence Barriers and Improve Adherence Among Nonadherent Patients with Comorbid Hypertension and Diabetes in a Medicare Advantage Plan.

Abughosh SM, Wang X, Serna O, Henges C, Masilamani S, Essien EJ, Chung N, Fleming M.

J Manag Care Spec Pharm. 2016 Jan;22(1):63-73. doi: 10.18553/jmcp.2016.22.1.63.

13.
14.

Does good medication adherence really save payers money?

Stuart BC, Dai M, Xu J, Loh FH, S Dougherty J.

Med Care. 2015 Jun;53(6):517-23. doi: 10.1097/MLR.0000000000000360.

PMID:
25961659
15.

Risk of Nondherence to Diabetes Medications Among Medicare Advantage Enrollees: Development of a Validated Risk Prediction Tool.

Mhatre SK, Serna O, Sansgiry S, Fleming ML, Essien EJ, Sansgiry SS.

J Manag Care Spec Pharm. 2016 Nov;22(11):1293-1301.

16.
17.

Guideline-recommended medications: variation across Medicare Advantage plans and associated mortality.

Selim AJ, Fincke BG, Rogers WH, Qian S, Selim BJ, Kazis LE.

J Manag Care Pharm. 2013 Mar;19(2):132-8.

18.
19.

Out-of-plan medication in Medicare Part D.

Roberto PN, Stuart B.

Am J Manag Care. 2014 Sep;20(9):743-8.

20.

Antiparkinson drug use and adherence in medicare part D beneficiaries with Parkinson's disease.

Wei YJ, Palumbo FB, Simoni-Wastila L, Shulman LM, Stuart B, Beardsley R, Brown C.

Clin Ther. 2013 Oct;35(10):1513-1525.e1. doi: 10.1016/j.clinthera.2013.09.001.

PMID:
24139423

Supplemental Content

Support Center